The
growing demand for charming smiles has led to the popularization
of tooth bleaching procedures. Current tooth bleaching products with
high-concentration hydrogen peroxide (HP, 30–40%) are effective
but detrimental due to the increased risk of enamel destruction, tooth
sensitivity, and gingival irritation. Herein, we reported a less-destructive
and efficient tooth whitening strategy with a low-concentration HP,
which was realized by the remarkably enhanced Fenton-like catalytic
activity of oxygen-deficient TiO2 (TiO2–x
). TiO2–x
nanoparticles
were synthesized with a modified solid-state chemical reduction approach
with NaBH4. The Fenton-like activity of TiO2–x
was optimized by manipulating oxygen vacancy (OV)
concentration and further promoted by the near-infrared (NIR)-induced
photothermal effect of TiO2–x
.
The TiO2–x
sample named BT45 was
chosen due to the highest methylene blue (MB) adsorption ability and
Fenton-like activity among acquired samples. The photothermal property
of BT45 under 808 nm NIR irradiation was verified and its enhancement
on Fenton-like activity was also studied. The BT45/HP + NIR group
performed significantly better in tooth whitening than the HP + NIR
group on various discolored teeth (stained by Orange II, tea, or rhodamine
B). Excitingly, the same tooth whitening performance as the Opalescence
Boost, a tooth bleaching product containing 40% HP, was obtained by
a self-produced bleaching gel based on this novel system containing
12% HP. Besides, negligible enamel destruction, safe temperature range,
and good cytocompatibility of TiO2–x
nanoparticles also demonstrated the safety of this tooth bleaching
strategy. This work indicated that the photothermal-enhanced Fenton-like
performance of the TiO2–x
-based
system is highly promising in tooth bleaching application and can
also be extended to other biomedical applications.
The effective treatment for periodontitis is to completely and sustainedly eradicate the bacterial pathogens from the complex periodontal pockets. Local sustained-release antibiotics as a complementary treatment after scaling and root planning can sustainedly combat bacterial pathogens in the periodontal pockets to help treat the disease, but the increasing concern of bacterial resistance limits its future use. Here, we reported a local antibacterial system based on microsized multifunctional Ag−TiO 2−x encapsulated in alginate (ATA) microspheres. We confirmed that ATA displayed strong photothermally enhanced dual enzyme-mimicking (peroxidase-like and catalase-like) activities and weak photocatalytic activity under 808 nm near-infrared (NIR) irradiation, which could boost the generation of reactive oxygen species (ROS) and O 2 in the presence of low-level H 2 O 2 . As a result, the ATA/H 2 O 2 /NIR system exhibited efficient antibacterial activity against Porphyromonas gingivalis and Streptococcus gordonii in both planktonic and biofilm forms. With the help of ROS, ATA could release Ag + in concentrations sufficient to inhibit periodontal pathogens as well. Moreover, the in situ-generated oxygen was supposed to alleviate the local hypoxic environment and would help downregulate the lipopolysaccharide-mediated inflammatory response of periodontal stem cells. The in vivo rat periodontitis treatment results demonstrated that the ATA/H 2 O 2 /NIR system reduced the bacterial load, relieved inflammation, and improved tissue healing. Our work developed a new local prolonged bactericidal and oxygenation system for enhanced periodontitis. Avoiding the usage of antibiotics and nanomaterials, this strategy showed great promise in adjunctive periodontitis treatment and also in other biomedical applications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.